From our Blog
FDA Approves Kisunla™ A New Drug for Alzheimer’s Treatment
Another important step forward in the fight against Alzheimer’s disease was reached last Tuesday, with the Food and Drug Administration (FDA) approval of Kisunla™ (generic name donanemab), developed by Eli Lilly. Kisunla™ is the third [View More]
Communication is Possible at Every Stage of Alzheimer’s Disease
Alzheimer’s disease can significantly impact a person’s language ability. Caregivers may notice a decline [View More]
Alzheimer’s Disease and Brain Health
Many factors can influence healthy aging. While some of these factors, such as genetics, are [View More]
Father’s Day: Celebrating Differently
This Sunday, on Father's Day, many families will gather to celebrate Dad. If Dad [View More]
Summer Travel Tips for People Living with Alzheimer’s Disease
For a person living with Alzheimer’s disease or another form of dementia, a “simple vacation” [View More]